Global prevalence of infections in newborns with respiratory complications: systematic review and meta-analysis

IF 1.3 Q4 MICROBIOLOGY Iranian Journal of Microbiology Pub Date : 2024-02-10 DOI:10.18502/ijm.v16i1.14867

Xiaoxiao Zhao, Nan Zhang

{"title":"Global prevalence of infections in newborns with respiratory complications: systematic review and meta-analysis","authors":"Xiaoxiao Zhao, Nan Zhang","doi":"10.18502/ijm.v16i1.14867","DOIUrl":null,"url":null,"abstract":"Background and Objectives: Newborns as a vulnerable population are exposed to congenital and acquired infections during and after birth. There are several reports of the isolation and reporting of infectious agents (IAs) in early life of newborns with respiratory manifestations, and the present comprehensive study provides a snapshot of the current global situation of the prevalence of IAs in newborns with respiratory symptoms. \nMaterials and Methods: A systematic search was conducted in main databases, including PubMed, Scopus, Web of science, and Google scholar. The pooled prevalence of infectious agents (IAs) in newborns was estimated using comprehensive me- ta-analysis software based on random effects model. \nResults: Out of 44 inclusive studies (50 datasets) for IAs in newborns, the pooled prevalence was estimated to be 12.2% (95% CI: 6.40-22.0%) and the highest and lowest prevalence of IAs was related to the Brazil (78.2%, 95% CI: 31.0-96.6%), and UK (0.01%, 95% CI 0.01-0.01%) respectively. \nConclusion: The high prevalence of IAs in newborns emphasizes considers the necessary measures to prevent respiratory infections.","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijm.v16i1.14867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and Objectives: Newborns as a vulnerable population are exposed to congenital and acquired infections during and after birth. There are several reports of the isolation and reporting of infectious agents (IAs) in early life of newborns with respiratory manifestations, and the present comprehensive study provides a snapshot of the current global situation of the prevalence of IAs in newborns with respiratory symptoms. Materials and Methods: A systematic search was conducted in main databases, including PubMed, Scopus, Web of science, and Google scholar. The pooled prevalence of infectious agents (IAs) in newborns was estimated using comprehensive me- ta-analysis software based on random effects model. Results: Out of 44 inclusive studies (50 datasets) for IAs in newborns, the pooled prevalence was estimated to be 12.2% (95% CI: 6.40-22.0%) and the highest and lowest prevalence of IAs was related to the Brazil (78.2%, 95% CI: 31.0-96.6%), and UK (0.01%, 95% CI 0.01-0.01%) respectively. Conclusion: The high prevalence of IAs in newborns emphasizes considers the necessary measures to prevent respiratory infections.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

全球新生儿呼吸道并发症感染率：系统回顾和荟萃分析

背景和目的：新生儿作为易感人群，在出生时和出生后都有可能受到先天性和后天性感染。目前已有多篇关于新生儿早期呼吸道症状感染病原体（IAs）的分离和报告的报道，本综合研究提供了当前全球新生儿呼吸道症状感染病原体流行情况的一个缩影。材料与方法：在主要数据库（包括 PubMed、Scopus、Web of science 和 Google scholar）中进行了系统检索。使用基于随机效应模型的综合me-ta分析软件估算了新生儿感染性病原体（IAs）的总流行率。结果：在 44 项关于新生儿感染性病原体的研究（50 个数据集）中，汇总的感染率估计为 12.2%（95% CI：6.40-22.0%），感染率最高和最低的国家分别是巴西（78.2%，95% CI：31.0-96.6%）和英国（0.01%，95% CI：0.01-0.01%）。结论新生儿呼吸道感染的高发病率强调了预防呼吸道感染的必要措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Iranian Journal of Microbiology MICROBIOLOGY-

CiteScore

2.40

自引率

7.10%

发文量

审稿时长

12 weeks

期刊介绍： The Iranian Journal of Microbiology (IJM) is an international, multi-disciplinary, peer-reviewed journal that provides rapid publication of the most advanced scientific research in the areas of basic and applied research on bacteria and other micro-organisms, including bacteria, viruses, yeasts, fungi, microalgae, and protozoa concerning the development of tools for diagnosis and disease control, epidemiology, antimicrobial agents, clinical microbiology, immunology, Genetics, Genomics and Molecular Biology. Contributions may be in the form of original research papers, review articles, short communications, case reports, technical reports, and letters to the Editor. Research findings must be novel and the original data must be available for review by the Editors, if necessary. Studies that are preliminary, of weak originality or merely descriptive as well as negative results are not appropriate for the journal. Papers considered for publication must be unpublished work (except in an abstract form) that is not under consideration for publication anywhere else, and all co-authors should have agreed to the submission. Manuscripts should be written in English.